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SUMMARY
Forty-five cases ofsystemic neonatal candidiasis were diagnosed over a 9-year
period in a neonatal intensive care unit; 42 infants weighed less than 1-5 kg. All
had been very ill with preceding bacterial sepsis and other complications oflow
birthweight. Where treatment was instituted the mortality was low (4 out of39
dying) and complications oftreatment were transitory. We therefore recommend
diligent examination for the presence of this infection, and treatment with a
combination of amphotericin B and 5-flucytosine.
INTRODUCTION
Sepsis remains an important cause of morbidity and mortality in the newborn
infant; especially so in infants of low birth weight requiring intensive care.'
Systemic candidiasis has become recognised as a significant cause of sepsis in
our unit over the past 9 years, and we have therefore analysed data on the 45
cases that have occurred during that period.
METHODS
Forty-five patients were diagnosed over a 9-year period (July 1980 - July
1989) as having systemic candidiasis in the Neonatal Intensive Care Unit, Royal
Maternity Hospital, Belfast. The diagnosis was established by the culture of
candida from venous blood and/or the finding of budding yeasts in urine
obtained by suprapubic aspiration, followed by subsequent culture of candida.
Cases diagnosed at postmortem by the finding of candidal abscesses in lung,
brain, heart and liver were included where the diagnosis had not been made
antemortem.
RESULTS
Forty-five infants (Table) were found to have systemic candidiasis. All were pre-
term, and lessthan 35 weeks gestation. Twenty-three were very immature, being
< 27 weeks gestation. Consequently the babies were small and 20 weighed less
than 1-0 kg. All the infants prior to the diagnosis of candidiasis had been very ill
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TABLE
Clinical details on 45 infants with systemic candidiasis
Mean Range
Gestation (weeks) 27-7 ± 2-3 25-34
Weight 1105 ± 342 537-2440




Blood and urine 19
CSF 6
Complicating disease:
Bronchopulmonary dysplasia 16 (37%)
Patent ductus arteriosus 17 (40%)
Congenital malformation 3 ( 7%)
with proven bacterial sepsis, the majority (84%) with staphylococcal septicaemia
(Staphylococcus aureus). All had received at least three courses of antibiotics,
with a mean of 5-5 courses. Forty (93%) had received cephalosporin treatment
as part ofthe antibiotic therapy. All had received periods ofassisted ventilation in
the treatment of respiratory failure secondary to respiratory distress syndrome,
pulmonaryimmaturityorpneumonia. Manyhadcomplicationsincludingbroncho-
pulmonary dysplasia or patent ductus arteriosus, prolonging their inpatient stay,
and increasing their morbidity. The great majority had the diagnosis made on
blood culture, and a number also had yeasts seen on direct examination of the
urine prior to culture. Less than half had combined positive urine and blood
cultures.
With the exception ofthose babies who were diagnosed at postmortem, the mean
age at diagnosis was 35 ± 20 days with a range from 9 -80 days. All the infants
had at some time arterial catheters, either umbilical or radial, in situ, but only
three infants had arterial catheters in situ at the time of diagnosis. Although all
infants were receiving intravenous feeding none had central catheters present at
the time of diagnosis.
There were 10 deaths. The diagnosis was established in five infants at post-
mortem; these infants were the first in our series and in one, although fungi
were found in tissues at postmortem, the main cause of death was a coliform
meningitis; the other four infants probably died from the effects of disseminated
candidiasis, the organism being found widely spread throughout lung, brain,
heart and liver. Of the other infants who eventually died following clinical and
laboratory diagnosis of infection, two died from respiratory failure secondary to
bronchopulmonary dysplasia, one from a complex cardiac malformation, one
from sudden infant death syndrome after discharge from hospital, and one from
candidiasis.
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The incidence of infection increased during the nine-year period reaching a
maximum of 10 cases in 1987. The most frequent presenting sign was apnoea,
seen in 21 infants, while in a further 21 the combination oflethargy, temperature
instability, colour change and hyperglycaemia was also seen. Seven presented
with abdominal distension, three with sclerema; most infants had more than one
sign or symptom.
The infants were treated withacombination ofamphotericin B between 0* 1 -0 5
mg/kg/day and flucytosine 100 mg/kg/day in two divided doses. The mean
length of treatment was 18 days, ranging from 1-42 days. None suffered any
obvious severe acute or long-term toxic effects from these drugs, with the
exception of a transient rise in liver enzymes in 15, and in a further eight a fall in
platelet count below 100,000 cumm during periodsoftreatment. Amphotericin B
and 5 -flucytosine levels were assayed, but levels above therapeutic recommend -
ations were not detected. Where treatment was instituted the outcome was
relatively satisfactory, in that only four of the 39 infants that were treated died.
One infant was not treated in view of his moribund state. On examining the
cause of death of those babies who died, it is probable that only one died from
candidiasis, the others dying some time after the infection had been eliminated,
and from some other disease or pathological condition.
Twenty-four of the 41 infants were known to be colonised with Candida spp.
prior to the diagnosis of systemic spread, a higher proportion than that found by
Faix et al.2 Five of our patients were colonised at birth and the remainder in the
subsequent two weeks. Therefore we now treat all infants in long,-term intensive
care with oral nystatin routinely where Candida spp. has been grown from super-
ficial swabs.
All the surviving infants have been followed up as outpatients. The oldest child at
the time of the last examination was aged 6 years and the youngest less than
6 months. Of the 29 infants of more than one year of age, 23 appeared to be
making adequate physical and developmental progress, four had moderate
developmental delay and two had cerebral palsy; whether these problems can be
attributed to candidiasis or other complications occurring during the perinatal
period is impossible to say.
DISCUSSION
Systemic candidiasis represents an important cause of morbidity and mortality in
our patients. It occurred in approximately 0 5% of low birth weight infants, but
was found in 11 % of those weighing less than 1
-0 kg. Very low birth weight has
also been recognised as important by Johnson et al I and Faix et al.2 The signs
and symptoms observed in these babies mimic bacterial sepsis, emphasising the
importance of routine fungal as well as bacterial culture in the investigation of
possible sepsis in infants of low birth weight, particularly those weighing less
than 1 * 5 kg.
It is encouraging that despite using drugsthought to be potentially toxic in adults,
none of the infants appeared to have suffered long-term ill-effects from
amphotericin or flucytosine. Some infants may have had transient hepatic and
haematological changes, but these findings may be related rather to the infection
than to the medication given. Smith and Congdon3 have commented on the
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difficulty of obtaining positive blood cultures, but we found the reverse: there
were more infants with positive blood cultures than with positive urinary findings.
A minority had both positive urine and blood findings. It remains to be seen
whether routine treatment with oral nystatin will significantly reduce the incidence
of local or systemic candidiasis either by its removal from the gut after birth, or
by reducing the incidence of cross-infection. At present we start treatment with
nystatin in those infants from whom Candida spp. are cultured and who are in
need of intensive care.
The main factors predisposing to infection in these infants appear to be their low
birth weight, their associated immunological immaturity and the breaching of
their physical defences following long periods ofintensive care, during which they
undergo invasive treatments such as artificial ventilation and vascular catheteris-
ation. The infants in ourseries who developed this infection were a more ill group
than the other infants treated in the unit over the same period; 100% required
ventilation as against 43%; 37% had bronchopulmonary dysplasia against
17%, and 40% had patent ductus arteriosus against 13% of the comparative
population. Despite the fact that 20 of these babies were less than 1 kg, 14
survived, a rate similar to babies weighing less than 1 kg who were cared for in
the ward during the period under consideration.
We see little prospect of this infection being eliminated, in view of the increasing
numbers oflow birth weight infants atpresentsurviving. Long periodsofintensive
care, due to the development of more sophisticated methods of treatment,
including better perinatal management and surfactant administration is the major
risk factor. We suggest that a high degree of awareness be maintained regarding
the possibility ofthis infection, and that the appropriate examination and cultures
of specimens from patients who may present with the rather vague clinical signs
and symptoms described be carried out. Where possible, vascular catheterisation
should be avoided, and most important of all, antibiotics should be given only
under sound bacteriological advice for minimal periods oftime. The Editor ofthe
Year Book of Pediatrics (1986)5 commented laconically "Some of these infants
of extremely low birth weight remain in the nursery so long, is it any wonder that
they become mouldy?"
We are appreciative of the helpful advice from Dr Hugh Webb and his colleagues in the Bacteriology
Laboratory, Royal Victoria Hospital, who undertook the culture of the specimens.
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